Today is good. According to relevant public information, 1, Shanghai Qianmai Medical Investment Management Co., Ltd. (hereinafter referred to as Qianmai Medical) was established in February 20 12, focusing on ICL business, and investing in biotechnology research and development, information technology, internet medical care, trade and other fields at the same time to enhance business competitiveness. With the deepening of the new medical reform process, the rise of personalized diagnosis and treatment, and the in-depth application of precision medicine, Qianmai Medical has developed the business model of independent medical laboratory, improved management and system, and devoted itself to the field of medical diagnosis with the concept of one sample and one commission, providing excellent services for human health and contributing to public health. Qianmai Group consists of reagent research and development, cold chain logistics, information technology, judicial expertise, rapid inspection (POL) platform, Internet and hospital. Form an upstream and downstream, multi-field, healthy and ecological development format around the whole life cycle, and help enterprises to continuously optimize and develop steadily. 2. Guangzhou Jinyu Medical Laboratory Group Co., Ltd., headquartered in Guangzhou, Guangdong Province, is a high-tech service enterprise focusing on third-party medical laboratory and pathological diagnosis. The core entrepreneurial team of Jinyu Medical has been actively exploring the operation mode of China medical inspection outsourcing service since the 1990s, creating a precedent for third-party medical inspection in China. Jinyu Medical is the first medical inspection institution in China that has passed the double certification of American Association of Clinicians. Guangzhou Jinyu Medical Inspection Center was formally established in 2003. Now it has developed into a market leader enterprise with the largest business scale, the widest market network and complete inspection items and technical platforms in the domestic third-party medical inspection industry. Jinyu Service occupies more than 30% of the market share of third-party medical inspection.